Use of “Limited Lead” ECG Devices

Learn more about the utility and use cases for limited lead ECG devices in clinical trials.



Use of “Limited Lead” ECG Devices

Learn more about the utility and use cases for limited lead ECG devices in clinical trials.
LEARN MORE

“These 6-lead ECGs may allow detection of many cardiac arrhythmias, and can often be used for detection of drug-related QTc prolongation.”


What’s inside The Use of “Limited Lead” ECG Devices whitepaper:

This whitepaper explores the newest technologies for recording electrocardiograms (ECGs) of varying durations. While these recorders have been in use since the 1980s, until recently, they couldn’t replace ECG devices in a clinical setting. During the past decade, new technologies have been developed to collect electrocardiographic recordings, even at home. Most recently, AliveCor has developed a device, KardiaMobile, that collects a 6 lead ECG in the comfort and convenience of your home.

Considering the current collection methodologies, which is right for use in a clinical trial? Robert Kleiman, MD, Chief Medical Officer and Todd Rudo, MD, Deputy Chief Medical Officer at ERT take a look at the history of ECG measurements, define current methodologies for ECG collection in clinical trials, and offer possible use cases for both 6-Lead and 12-Lead ECGs.

What you will learn about Limited Lead ECG Devices:

  1. How ECG technology has evolved over time
  2. The various devices currently being used in clinical trials
  3. When and why a 6-lead ECG may be useful over a 12-lead ECG and when it may not



ACCESS THE WHITE PAPER